摘要
目的:探讨用阿替普酶对急性脑梗死患者进行静脉溶栓治疗的临床效果。方法:抽选2017年5月至2019年5月在大庆油田总医院接受治疗的急性脑梗死患者120例作为研究对象。应用随机数表法将其分为Comparison组与Observation组。对两组患者均进行常规治疗。在此基础上,为Observation组患者应用阿替普酶进行静脉溶栓治疗。然后对比两组患者的治疗效果。结果:与Comparison组患者相比,Observation组患者治疗的有效率更高,P<0.05。治疗后,两组患者颅内出血的发生率及死亡率相比,P>0.05。结论:用阿替普酶对急性脑梗死患者进行静脉溶栓治疗可取得较为理想的效果,且安全性较高。
Objective:To investigate the clinical effect of intravenous thrombolysis with alteplase in patients with acute cerebral infarction.Methods:120 patients with acute cerebral infarction who were treated in Daqing Oilfield General Hospital from May 2017 to May 2019 were selected as the study subjects.They were divided into Comparison group and Observation group by random number table method.Both groups received routine treatment.On this basis,alteplase was used for intravenous thrombolysis for Observation group.The two groups were then compared.Results:Compared with Comparison group,Observation group had a higher effective rate of treatment(P<0.05).After treatment,the incidence and mortality of intracranial hemorrhage were compared between the two groups(P>0.05).Conclusion:Intravenous thrombolysis with alteplase is effective and safe in patients w ith acute cerebral infarction.
作者
杨丽丽
于洪玲
Yang Lili;Yu Hongling(Department of Neurology,Daqing Oilfield General Hospital,Daqing Heil ongjiang 163000)
关键词
急性脑梗死
阿替普酶
静脉溶栓
acute cerebral infarction
Alteplase
Intravenous thrombolysis
